Neurogene Inc (NGNE)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $482.33M
Last updated: Nov 17, 2026 at 4:10 PM ET
Neurogene Inc (NGNE) Stock Chart
Neurogene (NGNE) has a latest price of $23.10 on Nov 17, 2026, 47.1% below its 52-week high of $43.66. Its price rose 1.4% over the past 12 months. The month-end price fell 86.8% over the 10 years through Oct 2026, a compound annual decline of 18.4%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $361.20 in Jan 2017 and its lowest $10.07 in Feb 2023, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart NGNE with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NGNE.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 41.4%, and over 6 months it fell 14.1%. The month-end price rose 103.8% over the 3 years through Oct 2026, a compound annual rate of 26.8%.
| Period | Change |
|---|---|
| 1 month | -4.4% |
| 3 months | -41.4% |
| 6 months | -14.1% |
| 12 months | +1.4% |
| 12 months, with dividends | +1.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +103.8% | +26.8% |
| 5 years | -81.2% | -28.4% |
| 10 years | -86.8% | -18.4% |
Price by Year
Its best calendar year was 2019, when the price rose 470.4%, and its weakest was 2022, when it fell 89.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $27.55 | +33.7% |
| 2025 | $20.60 | -9.9% |
| 2024 | $22.86 | +18.0% |
| 2023 | $19.38 | +90.4% |
| 2022 | $10.18 | -89.4% |
| 2021 | $96.40 | -65.8% |
| 2020 | $282.00 | +14.4% |
| 2019 | $246.40 | +470.4% |
| 2018 | $43.20 | -81.6% |
| 2017 | $235.20 | -28.8% |
Trading Range
The price is 16.3% below its 50-day average of $27.61 and 18.1% below its 200-day average of $28.22.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $23.10 | |
| 52-week high | $43.66 | -47.1% |
| 52-week low | $15.93 | +45.0% |
| 50-day average | $27.61 | -16.3% |
| 200-day average | $28.22 | -18.1% |
Price Risk
Over 3 years, its largest fall from a peak was 89.7%.
| Measure | Value |
|---|---|
| 1-year beta | 1.44 |
| Largest fall, 1 year | -49.7% |
| Largest fall, 3 years | -89.7% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About NGNE
What is NGNE's 1-year price change?
Neurogene's price rose 1.4% over the past 12 months. With dividends included, the 12-month total return was 1.4%.
What is NGNE's 5-year price change?
Neurogene's month-end price fell 81.2% over the 5 years through Oct 2026, a compound annual decline of 28.4%. These figures leave out dividends.
What is NGNE's 52-week high and low?
Neurogene's 52-week high is $43.66 and its 52-week low is $15.93. Its latest price of $23.10 on Nov 17, 2026 is 47.1% below the high.
What is NGNE's beta?
Neurogene's 1-year beta against the S&P 500 is 1.44, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 49.7%.
Is the NGNE chart free?
Yes. Advanced Charting for NGNE is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
NGNE pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors